TPST: Margin dodolan resik Tempest Therapeutics

Logo perusahaan publik Tempest Therapeutics Inc (TPST)

Due to the humanitarian status of medicine, Tempest Therapeutics (TPST) operates within a secure US perimeter, shielded from geopolitical risks. The company's revenues are based on the commercialization of TPST-1120 for the therapy of solid tumors. The emerging small-molecule ecosystem enhances the body's immune response. Final sales margins illustrate operational efficiency, while the 0.00 metric reflects current profitability dynamics.

Margin dodolan perusahaan tempesttx.com (TPST): kanggo periode 04.07.2022 - 19.11.2026

Tempest Therapeutics (TPST) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
Pambiji fundamental perusahaan:Tempest Therapeutics, Inc. - TPST
Produk dadi Tempest Therapeutics Corp

Sales margins serve as a key indicator of the efficiency with which revenue is converted into net income. This metric determines the portion of profit remaining after deducting all operating and tax expenses. By analyzing net sales profitability, an investor identifies cycles of maximum profitability and points of critical profit compression. For Tempest Therapeutics (TPST), this indicator will reflect the future efficiency of commercializing liver cancer drugs. The trend of the curve will confirm the company's ability to monetize royalties from partners.

Karo sapa Tempest Therapeutics saingan

ONC: Margin dodolan resik|Margin resik Halozyme Inc. (HALO)|Margin resik RevMed|Rentabilitas dodolan resik AAPG (Ascentage Pharma Group)|Margin dodolan resik CGON|UroGen Pharma - Rentabilitas dodolan resik|Bicara Therapeutics - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik Personalis Inc PSNL|Erasca Oncology - Margin dodolan resik|Tingkat bathi resik DCTH (Delcath Corp)|YMAB: Margin dodolan resik|AURA - Margin dodolan perusahaan|CADL (Candel Therapeutics Inc.) - Margin dodolan resik|Rentabilitas dodolan resik ARAY (Accuray)|Rentabilitas dodolan miturut bathi resik SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Margin resik|Margin resik Citius Oncology, Inc. CTOR|HURA - Rentabilitas dodolan miturut bathi resik|protaratx.com - Margin dodolan resik|FATE - Margin dodolan resik|WHWK: Margin dodolan resik|TScan Therapeutics (TCRX) - Margin dodolan resik|Margin resik Champions Oncology|Margin resik XBIT|Margin dodolan resik CVM|Rentabilitas dodolan miturut bathi resik OS Therapies Inc. OSTX|Margin resik Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Margin resik|ANL - Margin resik|Margin resik verupharma.com|XLO: Margin dodolan resik|Enochian BioSciences (RENB) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik MURA|Kairos Pharma Ltd - Margin bathi resik|Margin dodolan resik OKUR|CytoMed Therapeutics Limited (GDTC) - Tingkat bathi miturut bathi resik|Margin dodolan resik CRIS (Curis, Inc.)|APLM: Rentabilitas dodolan resik|Tharimmune Corporation - Margin dodolan resik|ADVB: Margin resik|GNPX: Margin dodolan resik|CLDI (Calidi Biotherapeutics Inc.) - Margin resik|Margin resik Sunshine Biopharma, Inc.|Margin dodolan resik xeneticbio.com|Margin resik Salarius (SLRX)|Rentabilitas dodolan miturut bathi resik Purple Biotech PPBT|Margin resik American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Margin resik|Checkpoint Therapeutics Inc. - Margin dodolan resik|Tingkat bathi resik ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Rentabilitas dodolan miturut bathi resik|Ikena Oncology, Inc. - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik NTBL|VIRX: Tingkat bathi resik|Margin resik MorphoSys Corporation (MOR)|NAYA - Margin resik|Margin dodolan resik AAPGV (Ascentage)